Cargando…

Arsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity

Myeloid-derived suppressor cells (MDSCs), one of the major orchestrators of the immunosuppressive network, are associated with immune suppression and considered a prime target for cancer immunotherapy. At present, various strategies have been explored to deplete and/or inactivate MDSCs in vivo. In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Qingmin, Jiang, Jingwei, Chu, Zhaohui, Lin, Hao, Zhou, Xinli, Liang, Xiaohua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403453/ https://www.ncbi.nlm.nih.gov/pubmed/28454374 http://dx.doi.org/10.3892/ol.2017.5679

Ejemplares similares

MicroRNA expression profiles of granulocytic myeloid-derived suppressor cells from mice bearing Lewis lung carcinoma
por: Jiang, Jingwei, et al.
Publicado: (2016)

MiR‐486 promotes proliferation and suppresses apoptosis in myeloid cells by targeting Cebpa in vitro
por: Jiang, Jingwei, et al.
Publicado: (2018)

Curcumin Synergistically Enhances the Cytotoxicity of Arsenic Trioxide in U266 Cells by Increasing Arsenic Uptake
por: Han, Dingding, et al.
Publicado: (2021)

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide
por: Lin, Tseng-Hsi, et al.
Publicado: (2008)

Azacytidine sensitizes acute myeloid leukemia cells to arsenic trioxide by up-regulating the arsenic transporter aquaglyceroporin 9
por: Chau, David, et al.
Publicado: (2015)

MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide
por: Wang, Zhiguo, et al.
Publicado: (2019)

Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line
por: Li, Xiaofan, et al.
Publicado: (2016)

Vorinostat enhances chemosensitivity to arsenic trioxide in K562 cell line
por: Li, Nainong, et al.
Publicado: (2015)

Arsenic trioxide as an inducer of immunogenic cell death
por: Kepp, Oliver, et al.
Publicado: (2023)

Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along with Apoptosis in Acute Myeloid Cell Lines
por: Mohammadi Kian, Mahnaz, et al.
Publicado: (2020)

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017)

Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres
por: Ding, Dacheng, et al.
Publicado: (2014)

hsa-miR-203 enhances the sensitivity of leukemia cells to arsenic trioxide
por: HE, JIN-HUA, et al.
Publicado: (2013)

Ameliorative effects and mechanism of crocetin in arsenic trioxide-induced cardiotoxicity in rats
por: Zhao, Zhifeng, et al.
Publicado: (2020)

Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms
por: Tan, Ming, et al.
Publicado: (2019)

Arsenic trioxide inhibits EBV reactivation and promotes cell death in EBV-positive lymphoma cells
por: Yin, Qinyan, et al.
Publicado: (2017)

G-CSF upregulates the expression of aquaporin-9 through CEBPB to enhance the cytotoxic activity of arsenic trioxide to acute myeloid leukemia cells
por: Fu, Wanbin, et al.
Publicado: (2022)

Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway
por: Hu, Jiasheng, et al.
Publicado: (2013)

Inhibition of early T cell cytokine production by arsenic trioxide occurs independently of Nrf2
por: VanDenBerg, Kelly R., et al.
Publicado: (2017)

Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis
por: Zhang, Feng, et al.
Publicado: (2018)

Enhancement of Arsenic Trioxide-Mediated Changes in Human Induced Pluripotent Stem Cells (IPS)
por: Graham, Barbara, et al.
Publicado: (2014)

Targeting Catalase but Not Peroxiredoxins Enhances Arsenic Trioxide-Induced Apoptosis in K562 Cells
por: Song, Li-Li, et al.
Publicado: (2014)

Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth
por: Zhou, Wenchao, et al.
Publicado: (2015)

Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines
por: Haghi, Atousa, et al.
Publicado: (2017)

Correction to: Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms
por: Tan, Ming, et al.
Publicado: (2019)

Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
por: Cho, Hyunsoo, et al.
Publicado: (2021)

Factors Determining Sensitivity and Resistance of Tumor Cells to Arsenic Trioxide
por: Sertel, Serkan, et al.
Publicado: (2012)

Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells
por: Sun, Ramon C, et al.
Publicado: (2011)

Arsenic trioxide rewires mantle cell lymphoma response to bortezomib
por: Zhao, Ling-Ling, et al.
Publicado: (2015)

Establishment and characterization of arsenic trioxide resistant KB/ATO cells
por: Zhang, Yun-Kai, et al.
Publicado: (2017)

Vascular Disrupting Agent Arsenic Trioxide Enhances Thermoradiotherapy of Solid Tumors
por: Griffin, Robert J., et al.
Publicado: (2012)

Current Advances of Nanomedicines Delivering Arsenic Trioxide for Enhanced Tumor Therapy
por: Yu, Mengzhen, et al.
Publicado: (2022)

Arsenic trioxide inhibits glioma cell growth through induction of telomerase displacement and telomere dysfunction
por: Cheng, Ye, et al.
Publicado: (2016)

Arsenic trioxide induces regulatory functions of plasmacytoid dendritic cells through interferon-α inhibition
por: Ye, Yishan, et al.
Publicado: (2020)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

Arsenic Trioxide Enhances the Radiation Sensitivity of Androgen-Dependent and -Independent Human Prostate Cancer Cells
por: Chiu, Hui-Wen, et al.
Publicado: (2012)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dcv3u80epcurqruo8aduc1u455